Dr. Timothy Quezada, DO

Dr. Quezada practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Quezada's NPI, 1871942326, was assigned on June 6, 2016. Dr. Quezada graduated from LECOM at Seton Hill - Greensburg in 2016. Dr. Quezada holds Pennsylvania license OS020709.

Dr. Quezada's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Dr. Quezada's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Quezada is also affiliated with Wexford Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Quezada to 1 more hospital, 2 group practices and clinics, 1 breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quezada practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Quezada's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Quezada is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Quezada is licensed in Pennsylvania.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, seizures, stroke and vertigo among the conditions Dr. Quezada treats.

CMS data shows 414 Medicare services from Dr. Quezada across 10 procedure codes in 2024, for 303 Medicare patients. Medicare paid $38,440 for them.

CMS counts 303 Medicare patients who saw Dr. Quezada in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quezada's median patient age at 68, with 47% women.

In 2024, Dr. Quezada wrote 2,273 Medicare Part D claims for 264 patients. 87% of them were for generic drugs. CMS names the drug for 2,061 of them, across 38 drugs with 11 or more claims each, at $347,618 in total drug cost. In 2023, CMS named 1,549 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Quezada for performance year 2024, reported through an alternative payment model (APM). Dr. Quezada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Quezada as offering telehealth.

Dmand AI links 3 papers to Dr. Quezada, published from 2021 to 2023. Dr. Quezada's most frequent co-authors are Veli Bakalov, MD, Abhishek Chaturvedi, MD and Troy T. Desai, MD.

CMS Open Payments shows 33 general payments to Dr. Quezada from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. LivaNova USA, Inc. paid the most, $529.

Dr. Quezada graduated from LECOM at Seton Hill - Greensburg in 2016.

Dr. Quezada is in network with 17 carriers, including Aetna, Elevance and Highmark. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.